NU23-infected mice showed decreased allodynia after treatment with CCR2-RA, relative to the same mice prior to treatment (Fig. 5B), suggesting that CCR2 plays a role in chronic post-UTI pain induced by NU23. This evidence concerns the gene CCR2 and bacterial urinary tract infection.